SI1937687T1 - 7-(2-(4-(6-FLUORO-3-METIL-1,2-BENZISOKSAZOL-5-IL)-1-PIPERAZINIL)ETIL)2 -(1-PROPINIL)-7h-PIRAZOLO-(4,3-e)-(1,2,4)-TRIAZOLO-(1,5-c)-PIRIMIDIN -5-AMIN - Google Patents

7-(2-(4-(6-FLUORO-3-METIL-1,2-BENZISOKSAZOL-5-IL)-1-PIPERAZINIL)ETIL)2 -(1-PROPINIL)-7h-PIRAZOLO-(4,3-e)-(1,2,4)-TRIAZOLO-(1,5-c)-PIRIMIDIN -5-AMIN

Info

Publication number
SI1937687T1
SI1937687T1 SI200631017T SI200631017T SI1937687T1 SI 1937687 T1 SI1937687 T1 SI 1937687T1 SI 200631017 T SI200631017 T SI 200631017T SI 200631017 T SI200631017 T SI 200631017T SI 1937687 T1 SI1937687 T1 SI 1937687T1
Authority
SI
Slovenia
Prior art keywords
åethyl
benzisoxazol
triazolo
pyrazolo
pyrimidin
Prior art date
Application number
SI200631017T
Other languages
English (en)
Inventor
Craig D Boyle
Samuel Chackalamannil
Unmesh G Shah
Jean E Lachowicz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37487759&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1937687(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of SI1937687T1 publication Critical patent/SI1937687T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200631017T 2005-09-23 2006-09-21 7-(2-(4-(6-FLUORO-3-METIL-1,2-BENZISOKSAZOL-5-IL)-1-PIPERAZINIL)ETIL)2 -(1-PROPINIL)-7h-PIRAZOLO-(4,3-e)-(1,2,4)-TRIAZOLO-(1,5-c)-PIRIMIDIN -5-AMIN SI1937687T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72002705P 2005-09-23 2005-09-23
EP06804036A EP1937687B1 (en) 2005-09-23 2006-09-21 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE
PCT/US2006/037003 WO2007038284A1 (en) 2005-09-23 2006-09-21 7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-e]-[1,2,4]-TRIAZOLO-[1,5-c]-PYRIMIDIN-5 AMINE

Publications (1)

Publication Number Publication Date
SI1937687T1 true SI1937687T1 (sl) 2011-07-29

Family

ID=37487759

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200631017T SI1937687T1 (sl) 2005-09-23 2006-09-21 7-(2-(4-(6-FLUORO-3-METIL-1,2-BENZISOKSAZOL-5-IL)-1-PIPERAZINIL)ETIL)2 -(1-PROPINIL)-7h-PIRAZOLO-(4,3-e)-(1,2,4)-TRIAZOLO-(1,5-c)-PIRIMIDIN -5-AMIN

Country Status (31)

Country Link
US (2) US7572802B2 (sl)
EP (1) EP1937687B1 (sl)
JP (1) JP4808779B2 (sl)
KR (1) KR101396614B1 (sl)
CN (2) CN102716131B (sl)
AR (1) AR056080A1 (sl)
AT (1) ATE503759T1 (sl)
AU (1) AU2006294633B8 (sl)
BR (1) BRPI0616264B8 (sl)
CA (1) CA2623047C (sl)
CY (1) CY1111921T1 (sl)
DE (1) DE602006021042D1 (sl)
DK (1) DK1937687T3 (sl)
EC (1) ECSP088297A (sl)
ES (1) ES2361856T3 (sl)
HK (1) HK1119681A1 (sl)
HR (1) HRP20110466T1 (sl)
IL (1) IL190275A (sl)
MY (1) MY146429A (sl)
NO (1) NO341760B1 (sl)
NZ (1) NZ566737A (sl)
PE (1) PE20070521A1 (sl)
PL (1) PL1937687T3 (sl)
PT (1) PT1937687E (sl)
RS (1) RS51702B (sl)
RU (1) RU2417997C2 (sl)
SG (1) SG165419A1 (sl)
SI (1) SI1937687T1 (sl)
TW (1) TWI335329B (sl)
WO (1) WO2007038284A1 (sl)
ZA (1) ZA200802550B (sl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ527142A (en) 2003-07-23 2006-03-31 Douglas Pharmaceuticals Ltd A stable suspension formulation
US7723343B2 (en) 2007-03-30 2010-05-25 King Pharmaceuticals Research And Development, Inc. Adenosine A2A receptor antagonists
US8859566B2 (en) 2009-03-13 2014-10-14 Advinus Therapeutics Private Limited Substituted fused pyrimidine compounds
EP2462144B1 (en) * 2009-08-07 2017-09-20 Merck Sharp & Dohme Corp. PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
WO2011101861A1 (en) 2010-01-29 2011-08-25 Msn Laboratories Limited Process for preparation of dpp-iv inhibitors
WO2012038980A2 (en) * 2010-09-24 2012-03-29 Advinus Therapeutics Limited Fused tricyclic compounds as adenosine receptor antagonist
WO2012135083A1 (en) * 2011-03-31 2012-10-04 Merck Sharp & Dohme Corp. METABOLITES OF 7-(2-(4-(6-FLUORO-3-METHYLBENZO[d]ISOXAZOL-5-YL)PIPERAZIN-1-YL)ETHYL)-2-(PROP-1-YNYL)-7H-PYRAZOLO[4,3-e][1,2,4]TRIAZOLO[1,5-c]PYRIMIDIN-5-AMINE AND THEIR UTILITY AS ADENOSINE A2a RECEPTOR ANTAGONISTS
WO2014101113A1 (en) * 2012-12-28 2014-07-03 Merck Sharp & Dohme Corp. Piperazine-substituted 7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
WO2014101120A1 (en) * 2012-12-28 2014-07-03 Merck Sharp & Dohme Corp. Heterobicyclo-substituted-7-methoxy-[1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
WO2014128882A1 (ja) * 2013-02-21 2014-08-28 医療法人 和楽会 不安うつ病の治療薬
WO2015027431A1 (en) 2013-08-29 2015-03-05 Merck Sharp & Dohme Corp. 2,2-difluorodioxolo a2a receptor antagonists
AU2015341913B2 (en) 2014-11-03 2020-07-16 Iomet Pharma Ltd Pharmaceutical compound
WO2016089796A1 (en) * 2014-12-04 2016-06-09 Merck Sharp & Dohme Corp. Formulation inhibiting effects of low acid environment
CN106543095B (zh) * 2016-09-23 2019-03-05 江苏大学 一种基于2-羟基苯乙酮肟及其衍生物一锅制备苯并异噁唑的方法
WO2019118313A1 (en) 2017-12-13 2019-06-20 Merck Sharp & Dohme Corp. Imidazo [1,2-c] quinazolin-5-amine compounds with a2a antagonist properties
CN110742893B (zh) * 2018-07-23 2024-04-05 百济神州(北京)生物科技有限公司 A2a受体拮抗剂治疗癌症的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462170B (sv) 1987-10-27 1990-05-14 Aahlstrom Corp Avlaegsnande av loesta och kolloidala makromolekylaera organiska aemnen ur effluenter
IT1264901B1 (it) 1993-06-29 1996-10-17 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(15-c)pirimidine ad attivita' antagonista per il recettore a2 dell'adenosina
ATE208199T1 (de) 1993-07-27 2001-11-15 Kyowa Hakko Kogyo Kk Arzneimittel gegen parkinsonsche krankheit
IT1275420B (it) 1995-06-02 1997-08-05 Schering Plough S P A Metodo per misurare l'affinita' di legame al recettore a2a dell'adenosina di componenti di interesse farmacologico mediante l'uso del ligando triziato (3h)-sch 58261
IT1277392B1 (it) 1995-07-28 1997-11-10 Schering Plough S P A Analoghi eterociclici di 1,2,4-triazolo(1,5-c]pirimidine ad attivita' antagonista per il recettore a2a dell'adenosina
IT1291372B1 (it) 1997-05-21 1999-01-07 Schering Plough S P A Uso di analoghi eterociclici di 1,2,4-triazolo (1,5-c) pirimidine per la preparazione di medicamenti utili per il trattamento delle malattie
WO2001092264A1 (en) 2000-05-26 2001-12-06 Schering Corporation Adenosine a2a receptor antagonists
GB0100624D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds VII
JP4545437B2 (ja) 2001-10-15 2010-09-15 シェーリング コーポレイション アデノシンa2a受容体アンタゴニストとしてのイミダゾ(4,3−e)−1,2,4−トリアゾロ(1,5−c)ピリミジン
AU2003304527B2 (en) 2002-12-19 2010-09-09 Merck Sharp & Dohme Corp. Uses of adenosine A2a receptor antagonists
MY139344A (en) * 2003-04-23 2009-09-30 Schering Corp 2-alkynyl-and 2-alkenyl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine a2a receptor antagonists
WO2005103055A1 (en) 2004-04-21 2005-11-03 Schering Corporation PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO-[1,5-c]-PYRIMIDINE ADENOSINE A2A RECEPTOR ANTAGONISTS

Also Published As

Publication number Publication date
PE20070521A1 (es) 2007-07-13
KR101396614B1 (ko) 2014-05-16
US20070072867A1 (en) 2007-03-29
PT1937687E (pt) 2011-06-01
JP2009509959A (ja) 2009-03-12
ATE503759T1 (de) 2011-04-15
TWI335329B (en) 2011-01-01
ECSP088297A (es) 2008-04-28
DK1937687T3 (da) 2011-07-18
RS51702B (en) 2011-10-31
AU2006294633A8 (en) 2012-03-29
CN101273045A (zh) 2008-09-24
NO341760B1 (no) 2018-01-15
BRPI0616264B8 (pt) 2021-05-25
BRPI0616264B1 (pt) 2020-12-22
AU2006294633B2 (en) 2012-03-01
JP4808779B2 (ja) 2011-11-02
KR20080047423A (ko) 2008-05-28
WO2007038284A1 (en) 2007-04-05
NO20081924L (no) 2008-05-22
NZ566737A (en) 2011-09-30
EP1937687A1 (en) 2008-07-02
RU2008115239A (ru) 2009-10-27
AU2006294633A1 (en) 2007-04-05
PL1937687T3 (pl) 2011-09-30
RU2417997C2 (ru) 2011-05-10
CN102716131B (zh) 2014-04-23
AR056080A1 (es) 2007-09-19
CN102716131A (zh) 2012-10-10
EP1937687B1 (en) 2011-03-30
CN101273045B (zh) 2012-02-01
CY1111921T1 (el) 2015-11-04
BRPI0616264A2 (pt) 2011-06-14
TW200730531A (en) 2007-08-16
CA2623047C (en) 2013-04-23
DE602006021042D1 (de) 2011-05-12
HK1119681A1 (en) 2009-03-13
US7572802B2 (en) 2009-08-11
IL190275A0 (en) 2009-09-22
US20090270432A1 (en) 2009-10-29
US8389532B2 (en) 2013-03-05
ZA200802550B (en) 2009-06-24
MY146429A (en) 2012-08-15
ES2361856T3 (es) 2011-06-22
CA2623047A1 (en) 2007-04-05
IL190275A (en) 2014-06-30
AU2006294633B8 (en) 2012-03-29
SG165419A1 (en) 2010-10-28
HRP20110466T1 (hr) 2011-08-31

Similar Documents

Publication Publication Date Title
SI1937687T1 (sl) 7-(2-(4-(6-FLUORO-3-METIL-1,2-BENZISOKSAZOL-5-IL)-1-PIPERAZINIL)ETIL)2 -(1-PROPINIL)-7h-PIRAZOLO-(4,3-e)-(1,2,4)-TRIAZOLO-(1,5-c)-PIRIMIDIN -5-AMIN
IL183133A0 (en) Dibenzyl amine compounds and derivatives
GB2415516B (en) Valve arrangement
AU301941S (en) Clip for mask
GB0520746D0 (en) Valve arrangement
GB2422444B (en) Valve arrangement
IL183657A0 (en) Amide derivatives
GB0513804D0 (en) New mixture
EP1827710A4 (en) LINE TRACER
GB0425117D0 (en) Improved valve
IL179328A0 (en) Levalbuterol hydrochloride polymorph b
PL1798356T3 (pl) Układ cokołowego końcowego profilu tynkarskiego
EP1804796A4 (en) AMINO-SUBSTITUTED ARYLOXYBENZYLPIPERIDINE DERIVATIVES
AU302259S (en) Mask cushion clip
GB2435375C (en) Improved valve
GB2410426B (en) Adjustable seat
ZA200702343B (en) Aminoalcohol derivatives
ZA200704149B (en) Dibenzyl amine compounds and derivatives
ZA200705150B (en) Amide derivatives
GB0524839D0 (en) Gas distributor
AU306730S (en) Shower base
AU306571S (en) Shower base
AU306570S (en) Shower base
AU306569S (en) Shower base
AU306568S (en) Shower base